Table 1.
Baseline cohort demographics for the 74 included patients.
| Characteristics | Whole cohort n (%) or median [IQR] |
|---|---|
| Age, years | 47 [33.2–54.2] |
| Gender | |
| Female | 61 (82.4) |
| Male | 13 (17.6) |
| Body mass index (kg/m2) | 23.7 [21.5–26] |
| Risk factors for severe COVID-19 infections | |
| Yes | 20 (27) |
| No | 50 (67.6) |
| Not disclosed | 4 (5.4) |
| COVID-19-like symptoms between March and June 2020 | |
| Yes | 65 (87.8) |
| No | 8 (10.8) |
| Not disclosed | 1 (1.4) |
| COVID-19 symptoms (n = 65) | |
| Headaches | 46 (70.8) |
| Anosmia | 46 (70.8) |
| Ageusia | 44 (67.7) |
| Cough | 37 (56.9) |
| Fever | 35 (53.8) |
| Dyspnea | 26 (40) |
| Diarrhea | 24 (36.9) |
| Arthralgia | 12 (18.4) |
| Previous positive SARS-CoV-2 PCR | 39 (52.7) |
| Post-acute COVID-19 syndrome | 24 (32.4) |
| Asthenia | 12 (16.2) |
| Dyspnea | 10 (13.5) |
| Concentration disorder | 7 (9.5) |